Friday, July 17, 2009 1:36:44 AM
Latest News Headlines for Biopure Corp
Biopure Files For Bankruptcy Protection, Sets Asset Sale
Thursday 07/16/2009 5:28 PM ET - Dow Jones News
DOW JONES NEWSWIRES
Biopure Corp. (BPUR) filed for Chapter 11 bankruptcy protection to clear the way for the sale of its assets to OPK Biotech LLC.
Biopure, which develops technologies that intravenously deliver oxygen to body tissue, said five months ago that it was exploring options. At the time, the company also said its auditors had raised doubts about the company's ability to continue as a going concern. The Food and Drug Administration dealt another blow to the company when it put a trial for its Hemopure product on hold.
It appears that OXBO has outlasted the competition FWIW.
Biopure Files For Bankruptcy Protection, Sets Asset Sale
Thursday 07/16/2009 5:28 PM ET - Dow Jones News
DOW JONES NEWSWIRES
Biopure Corp. (BPUR) filed for Chapter 11 bankruptcy protection to clear the way for the sale of its assets to OPK Biotech LLC.
Biopure, which develops technologies that intravenously deliver oxygen to body tissue, said five months ago that it was exploring options. At the time, the company also said its auditors had raised doubts about the company's ability to continue as a going concern. The Food and Drug Administration dealt another blow to the company when it put a trial for its Hemopure product on hold.
It appears that OXBO has outlasted the competition FWIW.
Recent TENX News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/02/2026 04:15:29 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/24/2026 03:41:34 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/10/2026 11:48:55 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 11:32:44 AM
- Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/10/2026 11:00:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/09/2026 04:24:22 PM
- Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference • GlobeNewswire Inc. • 03/03/2026 12:00:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/12/2026 06:21:10 PM
- Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 • GlobeNewswire Inc. • 02/04/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 02:49:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 02:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 02:14:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 01:46:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 01:29:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 01:03:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 12:53:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2026 09:33:28 PM
